Paige: Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low...

Paige now holds six CE marks in its portfolio of clinical AI applications Paige Breast Lymph Node was first launched at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in March 2022 NEW YORK--(BUSINESS...

The world’s first Artificial Intelligence (AI) software that can accurately perform breast cancer diagnosis has received approval for implementation in the UK and EU. The breast cancer diagnosis technology – called PANProfiler – has been...